ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 434 filers reported holding ENCOMPASS HEALTH CORP in Q1 2024. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,916 | -2.7% | 28,715 | -2.0% | 0.01% | -28.6% |
| Q3 2023 | $1,969 | -8.0% | 29,315 | -7.3% | 0.01% | 0.0% |
| Q2 2023 | $2,141 | +23.3% | 31,615 | -1.5% | 0.01% | +16.7% |
| Q1 2023 | $1,737 | -32.2% | 32,104 | -25.1% | 0.01% | -33.3% |
| Q4 2022 | $2,562 | -99.9% | 42,839 | +0.0% | 0.01% | +28.6% |
| Q3 2022 | $1,937,000 | +3.8% | 42,819 | +2.3% | 0.01% | 0.0% |
| Q2 2022 | $1,866,000 | -39.9% | 41,861 | -4.2% | 0.01% | -30.0% |
| Q1 2022 | $3,106,000 | +1001.4% | 43,677 | +972.6% | 0.01% | +900.0% |
| Q4 2019 | $282,000 | -23.2% | 4,072 | -29.9% | 0.00% | -50.0% |
| Q3 2019 | $367,000 | +29.7% | 5,805 | +29.8% | 0.00% | +100.0% |
| Q2 2019 | $283,000 | -18.0% | 4,473 | -24.2% | 0.00% | -50.0% |
| Q1 2019 | $345,000 | -57.2% | 5,899 | -54.9% | 0.00% | -50.0% |
| Q4 2018 | $806,000 | -56.4% | 13,069 | -44.9% | 0.00% | -50.0% |
| Q3 2018 | $1,849,000 | +28.4% | 23,722 | +11.6% | 0.01% | +33.3% |
| Q2 2018 | $1,440,000 | – | 21,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 697,659 | $45,334,000 | 10.13% |
| JANA PARTNERS LLC | 1,741,513 | $113,164,000 | 10.12% |
| Endurant Capital Management LP | 276,105 | $17,941,000 | 5.31% |
| REINHART PARTNERS, LLC. | 726,140 | $47,184,000 | 3.55% |
| Prosight Management, LP | 107,921 | $7,013,000 | 3.34% |
| Advantage Alpha Capital Partners LP | 160,234 | $10,412,000 | 2.41% |
| RK Capital | 115,800 | $7,525,000 | 2.13% |
| Copeland Capital Management, LLC | 700,015 | $45,487,000 | 2.02% |
| Sivik Global Healthcare LLC | 65,000 | $4,224,000 | 1.82% |
| Walthausen & Co., LLC | 120,016 | $7,799,000 | 1.62% |